International Journal of Molecular SciencesGeneticsPeer-reviewed journal article
Intake of red and processed meat, use of non-steroid anti-inflammatory drugs, genetic variants and risk of colorectal cancer; a prospective study of the Danish \"Diet, Cancer and Health\" cohort
Vibeke Charlotte AnderseniD, Ulrich HalekohiD, Anne Marie TjønnelandiD, Ulla Birgitte VogeliD, Tine Iskov KoppiD
- Citations
- 25
- FWCI
- 1.04
- Field percentile
- top 23%
Abstract
Red and processed meat have been associated with increased risk of colorectal cancer (CRC), whereas long-term use of non-steroid anti-inflammatory drugs (NSAIDs) may reduce the risk. The aim was to investigate potential interactions between meat intake, NSAID use, and gene variants in fatty acid metabolism and NSAID pathways in relation to the risk of CRC. A nested case-cohort study of 1038 CRC cases and 1857 randomly selected participants from the Danish prospective \"Diet, Cancer and Health\" study encompassing 57,053 persons was performed using the Cox proportional hazard models. Gene variants in SLC25A20, PRKAB1, LPCAT1, PLA2G4A, ALOX5, PTGER3, TP53, CCAT2, TCF7L2, BCL2 were investigated. CCAT2 rs6983267 was associated with risk of CRC per se (p<0.01). Statistically significant interactions were found between intake of red and processed meat and CCAT2 rs6983267, TP53 rs1042522, LPCAT1 rs7737692, SLC25A20 rs7623023 (pinteraction=0.04, 0.04, 0.02, 0.03, respectively), and use of NSAID and alcohol intake and TP53 rs1042522 (pinteraction=0.04, 0.04, respectively) in relation to risk of CRC. No other consistent associations or interactions were found. This study replicated an association of CCAT2 rs6983267 with CRC and an interaction between TP53 rs1042522 and NSAID in relation to CRC. Interactions between genetic variants in fatty acid metabolism and NSAID pathway and intake of red and processed meat were found. Our results suggest that meat intake and NSAID use affect the same carcinogenic mechanisms. All new findings should be sought replicated in independent prospective studies. Future studies on the cancer-protective effects of aspirin/NSAID should include gene and meat assessments.\n\nAuthor SummaryIntake of red and processed meat has been associated with risk of cancer and in particular colorectal cancer. However, the underlying biological mechanisms are only incompletely understood. Gene-environment interaction analysis may be used for identifying underlying mechanisms for e.g. meat carcinogenesis. In this work, we have analyzed the interaction between the intake of red and processed meat, use of non-steroid anti-inflammatory drugs (including the anti-carcinogenic drug aspirin) and genetic variants. Our results suggest that meat intake and non-steroid anti-inflammatory drug use affect the same carcinogenic mechanisms. These results need to be replicated in other cohort studies with lifestyle information. If replicated, these results may have future implications for developing new strategies for preventing colorectal cancer and other cancers that share similar pathways.
- organism: human
- assay: GWAS summary statistics
- research focus: gene regulatory network inference
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dietary inclusion of nitrite-containing frankfurter exacerbates colorectal cancer pathology, alters metabolism and causes gut dybiosis in APCmin mice
W. Crowe, X. Pan, … B. D. Green·bioRxiv·Mar 17, 2022
- Interactions Between Dietary Metabolites and Regulatory Risk Variants for Human Colon Cancer
Tania Fabo, Robin M. Meyers, … Paul A. Khavari·bioRxiv·Sep 5, 2025
- Physical activity reduces colorectal cancer risk independent of BMI - A two-sample Mendelian randomisation study
Xiaomeng Zhang, Evropi Τheodoratou, … Maria N Timofeeva·bioRxiv·Oct 9, 2019
- Reduction, removal or replacement of sodium nitrite in a model of cured and cooked meat: a joint evaluation of consequences on microbiological issues in food safety, colon ecosystem and colorectal carcinogenesis
F. Gueraud, C. Buisson, … F. H. PIERRE·bioRxiv·Mar 24, 2023
- A combined proteomics and Mendelian randomization approach to investigate the effects of aspirin-targeted proteins on colorectal cancer
A. Nounu, A. Greenhough, … G. Rennert·bioRxiv·Aug 14, 2020
- Genetic Variation at 19q13.33 confers colorectal cancer risk through the interaction of mucosal expression of FUT2 and plasma vitamin B12 levels
Morven Allan, Vidya Rajasekaran, … Malcolm G. Dunlop·medRxiv·Jul 14, 2026